301 related articles for article (PubMed ID: 37496110)
1. Distinct characteristics of two types of alternative lengthening of telomeres in mouse embryonic stem cells.
Sung S; Kim E; Niida H; Kim C; Lee J
Nucleic Acids Res; 2023 Sep; 51(17):9122-9143. PubMed ID: 37496110
[TBL] [Abstract][Full Text] [Related]
2. Telomeres reforged with non-telomeric sequences in mouse embryonic stem cells.
Kim C; Sung S; Kim JS; Lee H; Jung Y; Shin S; Kim E; Seo JJ; Kim J; Kim D; Niida H; Kim VN; Park D; Lee J
Nat Commun; 2021 Feb; 12(1):1097. PubMed ID: 33597549
[TBL] [Abstract][Full Text] [Related]
3. DNA methylation mediated up-regulation of TERRA non-coding RNA is coincident with elongated telomeres in the human placenta.
Novakovic B; Napier CE; Vryer R; Dimitriadis E; Manuelpillai U; Sharkey A; Craig JM; Reddel RR; Saffery R
Mol Hum Reprod; 2016 Nov; 22(11):791-799. PubMed ID: 27604461
[TBL] [Abstract][Full Text] [Related]
4. Alternative mechanisms of telomere lengthening: permissive mutations, DNA repair proteins and tumorigenic progression.
Gocha ARS; Harris J; Groden J
Mutat Res; 2013; 743-744():142-150. PubMed ID: 23219603
[TBL] [Abstract][Full Text] [Related]
5. Effects of reconstitution of telomerase activity on telomere maintenance by the alternative lengthening of telomeres (ALT) pathway.
Grobelny JV; Kulp-McEliece M; Broccoli D
Hum Mol Genet; 2001 Sep; 10(18):1953-61. PubMed ID: 11555632
[TBL] [Abstract][Full Text] [Related]
6. Alternative Lengthening of Telomeres (ALT) in Tumors and Pluripotent Stem Cells.
Zhao S; Wang F; Liu L
Genes (Basel); 2019 Dec; 10(12):. PubMed ID: 31835618
[TBL] [Abstract][Full Text] [Related]
7. Alternative Lengthening of Telomeres is characterized by reduced compaction of telomeric chromatin.
Episkopou H; Draskovic I; Van Beneden A; Tilman G; Mattiussi M; Gobin M; Arnoult N; Londoño-Vallejo A; Decottignies A
Nucleic Acids Res; 2014 Apr; 42(7):4391-405. PubMed ID: 24500201
[TBL] [Abstract][Full Text] [Related]
8. Alternative lengthening of telomeres (ALT) cells viability is dependent on C-rich telomeric RNAs.
Rosso I; Jones-Weinert C; Rossiello F; Cabrini M; Brambillasca S; Munoz-Sagredo L; Lavagnino Z; Martini E; Tedone E; Garre' M; Aguado J; Parazzoli D; Mione M; Shay JW; Mercurio C; d'Adda di Fagagna F
Nat Commun; 2023 Nov; 14(1):7086. PubMed ID: 37925537
[TBL] [Abstract][Full Text] [Related]
9. Alternative Lengthening of Telomeres Mediated by Mitotic DNA Synthesis Engages Break-Induced Replication Processes.
Min J; Wright WE; Shay JW
Mol Cell Biol; 2017 Oct; 37(20):. PubMed ID: 28760773
[TBL] [Abstract][Full Text] [Related]
10. Telomere Length Maintenance in Cancer: At the Crossroad between Telomerase and Alternative Lengthening of Telomeres (ALT).
De Vitis M; Berardinelli F; Sgura A
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29463031
[TBL] [Abstract][Full Text] [Related]
11. Alternative Lengthening of Telomeres in the Budding Yeast
Cohn M; Andersson AK; Mateo RQ; Möller MC
G3 (Bethesda); 2019 Oct; 9(10):3345-3358. PubMed ID: 31427453
[TBL] [Abstract][Full Text] [Related]
12. Telomerase-independent telomere length maintenance in the absence of alternative lengthening of telomeres-associated promyelocytic leukemia bodies.
Fasching CL; Bower K; Reddel RR
Cancer Res; 2005 Apr; 65(7):2722-9. PubMed ID: 15805271
[TBL] [Abstract][Full Text] [Related]
13. Alternative lengthening of telomeres can be maintained by preferential elongation of lagging strands.
Min J; Wright WE; Shay JW
Nucleic Acids Res; 2017 Mar; 45(5):2615-2628. PubMed ID: 28082393
[TBL] [Abstract][Full Text] [Related]
14. Alternative lengthening of telomeres in cancer stem cells in vivo.
Bojovic B; Booth RE; Jin Y; Zhou X; Crowe DL
Oncogene; 2015 Jan; 34(5):611-20. PubMed ID: 24531712
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of the alternative lengthening of telomeres pathway by subtelomeric sequences in Saccharomyces cerevisiae.
Grandin N; Gallego ME; White CI; Charbonneau M
DNA Repair (Amst); 2020 Dec; 96():102996. PubMed ID: 33126043
[TBL] [Abstract][Full Text] [Related]
16. Alternative lengthening of telomeres: mechanism and the pathogenesis of cancer.
Mori JO; Keegan J; Flynn RL; Heaphy CM
J Clin Pathol; 2024 Jan; 77(2):82-86. PubMed ID: 37890990
[TBL] [Abstract][Full Text] [Related]
17. Telomere elongation via alternative lengthening of telomeres (ALT) and telomerase activation in primary metastatic medulloblastoma of childhood.
Minasi S; Baldi C; Pietsch T; Donofrio V; Pollo B; Antonelli M; Massimino M; Giangaspero F; Buttarelli FR
J Neurooncol; 2019 May; 142(3):435-444. PubMed ID: 30830680
[TBL] [Abstract][Full Text] [Related]
18. A preclinical mouse model of glioma with an alternative mechanism of telomere maintenance (ALT).
Jeitany M; Pineda JR; Liu Q; Porreca RM; Hoffschir F; Desmaze C; Silvestre DC; Mailliet P; Junier MP; Londoño-Vallejo A; Ségal-Bendirdjian E; Chneiweiss H; Boussin FD
Int J Cancer; 2015 Apr; 136(7):1546-58. PubMed ID: 25175359
[TBL] [Abstract][Full Text] [Related]
19. Alternative Lengthening of Telomeres and Chromatin Status.
Udroiu I; Sgura A
Genes (Basel); 2019 Dec; 11(1):. PubMed ID: 31905921
[TBL] [Abstract][Full Text] [Related]
20. Functional Loss of
Graham MK; Kim J; Da J; Brosnan-Cashman JA; Rizzo A; Baena Del Valle JA; Chia L; Rubenstein M; Davis C; Zheng Q; Cope L; Considine M; Haffner MC; De Marzo AM; Meeker AK; Heaphy CM
Mol Cancer Res; 2019 Dec; 17(12):2480-2491. PubMed ID: 31611308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
